Related Experiment Videos
The role of inflammation in plaque disruption and thrombosis
Insights
Inflammation plays a key role in the disruption of atherosclerotic plaques, leading to thrombosis and serious cardiovascular events like heart attacks. Understanding this link is crucial for developing new treatments.
Area of Science:
- Cardiovascular Science
- Pathophysiology
- Immunology
Background:
- Coronary atherosclerosis often leads to severe clinical events via thrombosis.
- Thrombosis typically arises from disrupted atherosclerotic plaques.
- Plaque disruption is associated with lipid-rich cores, thin caps, and inflammation.
Purpose of the Study:
- To review evidence linking inflammation to plaque disruption.
- To examine inflammation's role in subsequent thrombosis.
- To discuss the clinical implications of inflammation in atherosclerosis.
Main Methods:
- Literature review of existing studies.
- Analysis of pathophysiological mechanisms.
- Synthesis of evidence on inflammatory involvement.
Main Results:
- Inflammation is implicated in atherosclerotic plaque vulnerability.
- Inflammatory cells contribute to plaque rupture.
- Inflammation promotes thrombosis on disrupted plaques.
Conclusions:
- Inflammation is a critical factor in the development of acute coronary syndromes.
- Targeting inflammation may offer therapeutic strategies for atherosclerosis.
- Further research into inflammatory pathways is warranted.
Abstract:
Most of the serious clinical manifestations (such as unstable angina, acute MI, and many cases of sudden death) of coronary atherosclerosis result from thrombosis, usually occurring on a disrupted atherosclerotic plaque. Plaques prone to disruption have large lipid-rich cores with evidence of cap-thinning and active inflammation. Inflammatory cells may contribute to both plaque disruption and subsequent thrombosis. Here we review the evidence for the involvement of inflammation in plaque disruption and thrombosis and the potential clinical implications of this pathophysiologic paradigm.